Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk

Molecular Biology Reports

Volumn 40, Issue 1, 2013, Pages 449-455

  Magalhaes J F ^a   Cortinhas, A J ^b   Albuquerque, C M ^a   Baptista, C S ^a,c   Ribeiro, R ^d   Viegas, Carlos ^a,f   Matos, Augusto ^c   MacHado, João ^a   Pires, Maria A ^a,e   Guedes Pinto, Henrique ^a   Martins Bessa, A ^e   Leitao J C ^b   Bastos, E ^a  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b RESEARCH CENTER IN SPORTS SCIENCES   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^e UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^f UNIVERSITY OF MINHO   (Portugal)

Author keywords

Interleukin 6; Polymorphism; Prostate cancer; Risk

Indexed keywords

INTERLEUKIN 6;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DNA POLYMORPHISM; ETHNICITY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IL6 GENE; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PROMOTER REGION; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN FUNCTION; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PUBLICATION BIAS;

EID: 84871289888     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2079-9     Document Type: Article

References (24)

1. Baade PD, Youlden DR, Kmjacki LJ (2009) International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 53(2):171-184
2. Schulz WA, Burchardt M, Cronauer MV (2003) Molecular biology of prostate cancer. Mol Hum Reprod 9(8):437-448. doi: 10.1093/molehr/gag064
3. Hughes C, Murphy A, Martin C, Sheils O, O′Leary J (2005) Molecular pathology of prostate cancer. J Clin Pathol 58(7):673-684. doi: 10.1136/jcp.2002.003954
4. Shen MM, Abate-Shen C (2010) Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 24(18):1967-2000. doi: 10.1101/gad.1965810
5. Tan D, Wu X, Hou M, Lee SO, Lou W, Wang J, Janarthan B, Nallapareddy S, Trump DL, Gao AC (2005) Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol 174(2):753-756. doi: 10.1097/01.ju. 0000168723.42824.40
6. Culig Z, Puhr M (2011) Interleukin-6: a multifunctional targetable cytokine in human prostate cancer. Mol Cell Endocrinol. doi: 10.1016/j.mce.2011.05.033
7. Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, Min ZC, Tao J, Li PC, Zhang W, Wu HF, Zhang ZD, Wang ZJ, Hua LX, Feng NH, Wang XR (2011) IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Biol Rep 38(4):2589-2596. doi: 10.1007/s11033-010-0399- 1
8. Pierce BL, Biggs ML, DeCambre M, Reiner AP, Li C, Fitzpatrick A, Carlson CS, Stanford JL, Austin MA (2009) C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65years and older. Cancer Causes Control 20(7):1193-1203. doi: 10.1007/s10552-009-9320-4
9. Morgan L, Cooper J, Montgomery H, Kitchen N, Humphries SE (2006) The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry 77(8):915-917. doi: 10.1136/jnnp.2005.081976
10. Sun J, Hedelin M, Zheng SL, Adami HO, Bensen J, Augustsson-Balter K, Chang B, Adolfsson J, Adams T, Turner A, Meyers DA, Isaacs WB, Xu J, Gronberg H (2004) Interleukin-6 sequence variants are not associated with prostate cancer risk. Cancer Epidemiol Biomark Prev 13(10):1677-1679
11. Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB (2006) Genetic polymorphisms of Interleukin-1B(IL- 1B), IL-6, IL-8 and IL-10 and risk of prostate cancer. Cancer Res 66(8):4525-4530. doi: 1158/0008-5472.CAN-05-3987
12. Bao S, Yang W, Zhou S, Ye Z (2008) Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer. J Huazhong Univ Sci Technol 28(6):693-696. doi: 10.1007/s11596-008-0618-3
13. Kesarwani P, Ahirwar DK, Mandhani A, Mittal RD (2008) Association between -174 G/C promoter polymorphism of the Interleukin-6 gene and progression of prostate cancer in North Indian population. DNA Cell Biol 27(9):505-509. doi: 10.1089/dna.2008.0742
14. Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U, Gunter MJ (2009) Adipokine genes and prostate cancer risk. Int J Cancer 124(4):869-876. doi: 10.1002/ijc.24043
15. Wang M, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V, Marzo AM, Isaacs WB, Drake CG, Shugart YY, Platz EA (2009) Association of IL-10 and other immune response-and obesity-related genes with prostate cancer in CLUE II. Prostate 69(8):874-885. doi: 10.1002/pros.20933
16. Zabaleta J, Su LJ, Lin HY, Sierra RA, Hall MC, Sartor AO, Clark PE, Hu JJ, Ochoa AC (2009) Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis 30(8):1358-1362. doi: 10.1093/carcin/bgp124
17. Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannuci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Marchand LL, Lund E, Peeters PHM, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler G, Cox DG (2010) PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium. Carcinogenesis 31(3):455-461. doi: 10.1093/carcin/bgp307
18. Howell WM, Rose-Zerilli MJ (2007) Cytokine gene polymorphisms, cancer susceptibility and prognosis. J Nutr 137:194-199
19. Ahn HM, Park IS, Hong SJ, Hong YM (2011) Interleukin-6 (-636C/G) gene polymorphism in Korean children with Kawasaki Disease. Korean Soc Cardiol 41(6):321-325. doi: 104070/kcj.2011.41.6.321
20. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102(7):1369-1376. doi: 10.1172/JCI2629
21. Kishimoto T (2005) Interleukin-6: from basic science to medicine. Annu Rev Immunol 23:1-21. doi: 10.1146/annurev.immunol.23.021704.115806
22. Terakawa T, Miyake H, Furukawa J, Ettinger SL, Gleave ME, Fujisawa M (2009) Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells. Br J Cancer 101:1731-1739. doi: 10.1038/sj.bjc.6605358
23. Lyman GH, Kuderer NM (2005) The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol 5(14):1-17. doi: 10.1186/1471-2288-5-14
24. Walker E, Hernandez AV, Kattan MW (2008) Meta-analysis: its strengths and limitations. Cleve Clin J Med 75(6):431-439. doi: 10.3949/ccjm.75.6.431